Navigation Links
Bronchial Thermoplasty: Boon to Severe Asthma Patients?

Encouraging results for the use of bronchial thermoplasty procedure were reported by the Research in Severe Asthma (RISA) Trial , at the annual scientific assembly of the American Thoracic Society (ATS) by Neil Thomson,MD, Professor of Respiratory Medicine, University of Glasgow, Scotland. This announcement came from Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma.

Severe asthma patients who underwent bronchial thermoplasty showed significant improvements in asthma control, pulmonary function and quality of life. There was also lesser use of rescue medications. The novel, non-drug procedure is under clinical investigation in the United States.

The RISA Trial was conducted at a total of eight hospitals, in three countries, and evaluated the safety and efficacy of bronchial thermoplasty in 32 adult subjects with severe persistent asthma who remained symptomatic despite taking regular asthma medications.

Compared to patients who received only standard asthma medications, patients who received the bronchial thermoplasty procedure and standard medications showed clinically and statistically significant improvements in pulmonary function, quality of life, and asthma control, and used less rescue medication nearly 6 months following the procedure.

One year following the treatment, 50% of bronchial thermoplasty treated patients were able to wean completely off oral corticosteroids (OCS), compared to 14% of patients who did not receive the treatment. Further, a greater overall reduction in OCS dose was observed at 52 weeks in the bronchial thermoplasty treated patients compared with those that did not receive treatment at 52 weeks, although this difference didnt reach statistical significance. The study was not powered to show statistical significance in medication changes.

In this group of patients with severe asthma, an increase in respi ratory-related symptoms, and hospitalizations related to these symptoms, were expected and observed during the period immediately following the procedure. These symptoms were of the type expected following bronchoscopy in patients with asthma, and they resolved on average within seven days.

"Following bronchial thermoplasty, patients with severe, refractory asthma demonstrated significant improvements in pulmonary function and asthma control," states Dr. Thomson. "These significant and seemingly long-lasting improvements came at the cost of a short-term increase in hospitalizations, but the apparent benefits seem to be greater than the manageable consequences of the procedure."

"The results from this randomized, controlled, multi-center trial provide some hope for patients with severe, refractory asthma people who despite taking state-of-the-art medications are still experiencing the disruptive and distressing symptoms of their asthma," states Glen French, CEO of Asthmatx, Inc. "We were particularly encouraged by the data that suggested that patients may be able to reduce their oral steroid dose and still maintain their asthma control."


'"/>




Related medicine news :

1. New Drug for Bronchial Asthma
2. Bronchial thermoplasty – a promising treatment for asthmatic
3. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
4. Severe stress weakens immunity
5. Severe Acute respiratory Syndrome (SARS)
6. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
7. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
8. Severe sleep apnea can cause liver problems
9. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
10. Strong Magnetic Stimulation Can Help Treating Severe Depression
11. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
Breaking Medicine Technology: